latest update:
[RxAtlas]

drug summary · 2 NDC codes

REBIF REBIDOSE 22 ug/.5mL

INTERFERON BETA-1A

HUMAN PRESCRIPTION DRUG record from the RxAtlas dataset, marketing status BLA. Facts and NDC codes below are exported values from the current release, not inferred or edited prose.

dataset id 2860NDC codes 2application BLA103780RxCUI —

Facts

Field definitions, types, and provenance rules are in the data dictionary.

generic nameINTERFERON BETA-1A
active ingredientsINTERFERON BETA-1A
dosage formINJECTION, SOLUTION
routeSUBCUTANEOUS
strength22 ug/.5mL
marketing statusBLA
DEA schedulenot reported
application numberBLA103780
ATC codenot reported
RxCUInot reported
manufacturerEMD Serono, Inc.
product typeHUMAN PRESCRIPTION DRUG
pharmacologic classInterferon beta [EPC]; Interferon-beta [CS]

NDC codes

2 National Drug Codes are mapped to this product in the current release. Package descriptions are not part of the published export, so the NDC code is the canonical package identifier here.

NDCPackage description
44087-3322—
44087332201—

Other INTERFERON BETA-1A products

5 other products in the current release publish the same generic name. Strength, dosage form, and labeler are what distinguish them.

Work with this record

  • Field definitions

    Types, scope, and provenance rules for every exported field.

  • REST API

    Query the same gate-backed records programmatically.

  • Evaluation sample

    Download a bounded slice before buying.

  • $29 API Pass

    Seven days of REST and MCP access to the full catalogue; credited toward the licence.